Catherine Leith, MD close
Catherine Leith, MD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Catherine Leith, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Catherine Leith, MD, earned her medical degree from King's College in England and completed her residency at the University of Arizona Health Sciences Center in Tucson, Arizona.




University Hospital
(608) 263-8443 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Pathology and Laboratory Medicine

Professional Certifications and Education

Board Certification Anatomic & Clinical Pathology
Residency University of Arizona Health Sciences Center, Tucson, AZ
Internship Gillingham Hospital, Kent, England
Medical School King's College London, London, England

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Hupp MM Bashleben C Cardinali JL Dorfman DM Karlon W Keeney M Leith C Long T Murphy CE Pillai V Rosado FN Seegmiller AC Linden MA Participation in the College of American Pathologists Laboratory Accreditation Program Decreases Variability in B-Lymphoblastic Leukemia and Plasma Cell Myeloma Flow Cytometric Minimal Residual Disease Testing: A Follow-up Survey. Arch Pathol Lab Med . 2021 Mar 1;145(3):336-342
[PubMed ID: 32886757]
Dhakal B Pagenkopf A Mushtaq MU Cunningham AM Flietner E Morrow Z Papadas A Hope C Leith C Hematti P Hari P Callander NS Asimakopoulos F Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma. Leuk Lymphoma . 2019 Oct;60(10):2558-2562
[PubMed ID: 30845856]
Leith CP Cost-Effective Flow Cytometry Testing Strategies. Clin Lab Med . 2017 Dec;37(4):915-929
[PubMed ID: 29128076]
Elsaid MY Gill KG Gosain A Nichol PF Leys CM Buehler D Leith CP Patel NJ Synchronous Presentation of Renal Cell Carcinoma and Hodgkin Lymphoma in an Adolescent. J Pediatr Hematol Oncol . 2017 Oct;39(7):e399-e402
[PubMed ID: 28092312]
Hope C Foulcer S Jagodinsky J Chen SX Jensen JL Patel S Leith C Maroulakou I Callander N Miyamoto S Hematti P Apte SS Asimakopoulos F Immunoregulatory roles of versican proteolysis in the myeloma microenvironment. Blood . 2016 Aug 4;128(5):680-5
[PubMed ID: 27259980]
Covach A Leith CP Rajguru SA Yang DT A unique CD4+ large granular lymphocytosis occurring in patients treated with tumor necrosis factor α inhibitors: report of 2 cases. Hum Pathol . 2015 Aug;46(8):1237-41
[PubMed ID: 26022501]
Oberley MJ Fitzgerald S Yang DT Morgan A Johnson J Leith C Value-based flow testing of chronic lymphoproliferative disorders: a quality improvement project to develop an algorithm to streamline testing and reduce costs. Am J Clin Pathol . 2014 Sep;142(3):411-8
[PubMed ID: 25125633]
Hope C Ollar SJ Heninger E Hebron E Jensen JL Kim J Maroulakou I Miyamoto S Leith C Yang DT Callander N Hematti P Chesi M Bergsagel PL Asimakopoulos F TPL2 kinase regulates the inflammatory milieu of the myeloma niche. Blood . 2014 May 22;123(21):3305-15
[PubMed ID: 24723682]
Xiao J Selvaggi SM Leith CP Fitzgerald SA Stewart J 3rd Kaposi sarcoma herpesvirus/human herpesvirus-8-negative effusion-based lymphoma: report of 3 cases and review of the literature. Cancer Cytopathol . 2013 Nov;121(11):661-9
[PubMed ID: 23765802]
Yang DT Quann PJ Petrich AM Leith CP Young KH Kahl BS Use of tissue microarray and automated quantitative analysis for screening and validation of potential biomarkers in mantle cell lymphoma. Appl Immunohistochem Mol Morphol . 2011 Jan;19(1):62-9
[PubMed ID: 20881841]
Markovina S Callander NS O'Connor SL Xu G Shi Y Leith CP Kim K Trivedi P Kim J Hematti P Miyamoto S Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-kappaB activity in myeloma cells. Mol Cancer . 2010 Jul 6;9:176
[PubMed ID: 20604947]
Markovina S Callander NS O'Connor SL Kim J Werndli JE Raschko M Leith CP Kahl BS Kim K Miyamoto S Bortezomib-resistant nuclear factor-kappaB activity in multiple myeloma cells. Mol Cancer Res . 2008 Aug;6(8):1356-64
[PubMed ID: 18708367]
Liu G Kolesar J McNeel DG Leith C Schell K Eickhoff J Lee F Traynor A Marnocha R Alberti D Zwiebel J Wilding G A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumors. Clin Cancer Res . 2008 May 1;14(9):2732-9
[PubMed ID: 18451239]
Wheeler DL Reddig PJ Ness KJ Leith CP Oberley TD Verma AK Overexpression of protein kinase C-{epsilon} in the mouse epidermis leads to a spontaneous myeloproliferative-like disease. Am J Pathol . 2005 Jan;166(1):117-26
[PubMed ID: 15632005]